arithmos— AI-powered custom index builder. You’re viewing a shared index.
Index
Continuous Glucose Monitor Index
official“An index of medtech companies leveraged to the continuous glucose monitor (CGM) and connected diabetes care category.”
built · 2026-04-30 21:38·rebalance · semiannual·next run · 2026-10-30
creator narrative
0/1000
backtest · S&P 500 (SPX)·range
CAGR—
Annual vol—
Sharpe—
Sortino—
Max drawdown—
Best year—
Worst year—
risk-free raterf = 4.50%
vs S&P 500 (SPX) · 1M—
vs S&P 500 (SPX) · 1Y—
vs S&P 500 (SPX) · 2Y—
vs S&P 500 (SPX) · 3Y—
vs S&P 500 (SPX) · 5Y—
vs S&P 500 (SPX) · 10Y—
no backtest data
attribution factsheet
holdings · 7
click a row to drill in ↗NameAllocation· cap 30%Rationale
DXCMDexComHealthcare30.00%G7 + Stelo OTC CGM franchise leader.ABTAbbott LaboratoriesHealthcare25.00%FreeStyle Libre — largest global CGM platform by users.MDTMedtronicHealthcare13.00%780G insulin pump + Simplera CGM integrated diabetes platform.TNDMTandem Diabetes CareHealthcare12.00%t:slim X2 pump integrated with DexCom and Abbott CGMs.INSPInspire Medical SystemsHealthcare8.00%Sleep-apnea adjacency for diabetic comorbidity treatment.PODDInsuletHealthcare7.00%Omnipod 5 automated insulin delivery with CGM integration.MASIMasimoHealthcare5.00%Hospital-grade noninvasive monitoring expanding into glucose.
▾
▾
▾
▾
▾
▾
▾
weighting · market_cap · cap=30%
rebalance · semiannual